Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Tsai, Yu Kuo ^a   Liou, Ci Hong ^b   Fung, Chang Phone ^c   Lin, Jung Chung ^b   Siu, L Kristopher ^a,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CARBAPENEMASE; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORINASE; CIPROFLOXACIN; CLAVULANIC ACID; DORIPENEM; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PORIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ENGINEERING; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PORINS;

EID: 84896702014     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079640     Document Type: Article

References (28)

1. Livermore DM (2012) Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 27: 128-142. doi: 10.3346/jkms.2012.27.2.128. PubMed: 22707882.
2. Chong Y, Ito Y, Kamimura T (2011) Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Genet Evol 11: 1499-1504. doi: 10.1016/j.meegid.2011.06.001. PubMed: 21689785.
3. Jacoby GA (2009) AmpC β-lactamases. Clin Microbiol Rev 22: 161-182. doi:10.1128/CMR.00036-08. PubMed: 19136439.
4. Yan JJ, Hsueh PR, Lu JJ, Chang FY, Shyr JM et al. (2006) Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother 50: 1861-1864. doi:10.1128/AAC.50.5.1861-1864.2006. PubMed: 16641462.
5. Shin SY, Bae IK, Kim J, Jeong SH, Yong D et al. (2012) Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36. J Med Microbiol 61: 239-245. doi:10.1099/jmm.0. 037036-0. PubMed: 21940650.
6. Chudácková E, Bergerová T, Fajfrlík K, Cervená D, Urbásková P et al. (2010) Carbapenem- nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 β-lactamases in a Czech hospital. FEMS Microbiol Lett 309: 62-70. PubMed: 20528936.
7. Wang XD, Cai JC, Zhou HW, Zhang R, Chen GX (2009) Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated β-lactamase production and OmpK36 porin deficiency. J Med Microbiol 58: 1196-1202. doi:10.1099/jmm.0.008094-0. PubMed: 19528170.
8. Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase- producing Enterobacteriaceae. Emerg Infect Dis 17: 1791-1798. doi:10.3201/eid1710.110655. PubMed: 22000347.
9. Tsai YK, Fung CP, Lin JC, Chen JH, Chang FY et al. (2011) Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55: 1485-1493. doi:10.1128/AAC.01275-10. PubMed: 21282452.
10. Ho PL, Shek RH, Chow KH, Duan RS, Mak GC et al. (2005) Detection and characterization of extended-spectrum β-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J Antimicrob Chemother 55: 326-332. (Pubitemid 40425457)
11. Siu LK, Lin JC, Gomez E, Eng R, Chiang T (2012) Virulence and plasmid transferability of KPC Klebsiella pneumoniae at the Veterans Affairs Healthcare System of New Jersey. Microb Drug Resist 18: 380-384. doi:10.1089/mdr.2011.0241. PubMed: 22533374.
12. Ohtomo R, Saito M (2003) A new selective medium for detection of Klebsiella from dairy environments. Microbes Environ 18: 138-144. doi: 10.1264/jsme2.18.138.
13. CLSI (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-ninth edition. CLSI Document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
14. CLSI (2013). erformance standards for antimicrobial susceptibility testing; Twenty-third informational supplement. CLSI Document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
15. Girlich D, Poirel L, Nordmann P (2009) CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 53: 832-834. doi: 10.1128/AAC.01007-08. PubMed: 19029330.
16. Girlich D, Poirel L, Nordmann P (2008) Do CTX-M β-lactamases hydrolyse ertapenem? J Antimicrob Chemother 62: 1155-1156. doi: 10.1093/jac/dkn317. PubMed: 18662942.
17. Elliott E, Brink AJ, van Greune J, Els Z, Woodford N et al. (2006) In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin Infect Dis 42: e95-e98. doi:10.1086/498517. PubMed: 16652304.
18. Doumith M, Ellington MJ, Livermore DM, Woodford N (2009) Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63: 659-667. doi:10.1093/jac/dkp029. PubMed: 19233898.
19. Barnaud G, Arlet G, Verdet C, Gaillot O, Lagrange PH et al. (1998) Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 42: 2352-2358. PubMed: 9736562. (Pubitemid 28420377)
20. Hanson ND, Sanders CC (1999) Regulation of inducible AmpC β-lactamase expression among Enterobacteriaceae. Curr Pharm Des 5: 881-894. PubMed: 10539994.
21. Jacobs C, Frère JM, Normark S (1997) Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in gram-negative bacteria. Cell 88: 823-832. doi:10.1016/S0092- 8674(00)81928-5. PubMed: 9118225. (Pubitemid 27164270)
22. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT (1994) Bacterial cell wall recycling provides cytosolic muropeptides as effectors for β-lactamase induction. EMBO J 13: 4684-4694. PubMed: 7925310. (Pubitemid 24310220)
23. Lindberg F, Westman L, Normark S (1985) Regulatory components in Citrobacter freundii ampC β-lactamase induction. Proc Natl Acad Sci U-S-A 82: 4620-4624. doi:10.1073/pnas.82.14.4620. PubMed: 2991883.
24. Vading M, Samuelsen O, Haldorsen B, Sundsfjord AS, Giske CG (2011) Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems. Clin Microbiol Infect 17: 668-674. doi: 10.1111/j.1469-0691. 2010.03299.x. PubMed: 20649801.
25. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B et al. (2007) Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45: 2723-2725. doi:10.1128/JCM.00015-07. PubMed: 17581941. (Pubitemid 47295515)
26. Woodford N, Dallow JW, Hill RL, Palepou MF, Pike R et al. (2007) Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int J Antimicrob Agents 29: 456-459. doi:10.1016/S0924- 8579(07)71461-9. PubMed: 17293088. (Pubitemid 46349596)
27. NDM-1 in Taiwan. J Chin Med Assoc 73: 596-598. doi:10.1016/S1726-4901(10)70129-5. PubMed: 21093828.
28. Yi H, Cho YJ, Yong D, Chun J (2012) Genome sequence of Escherichia coli J53, a reference strain for genetic studies. J Bacteriol 194: 3742-3743. doi:10.1128/JB.00641-12. PubMed: 22740669.